Press release
Clinical Trial Imaging Market by 2026 - Global Trends, Share Analysis, Leading Players, Business Opportunities
Clinical Trial Imaging Market
Increase in R&D spending;
Pharmaceutical and biotechnology companies invest heavily in research to develop breakthrough molecules. Growth in the R&D expenditure by pharmaceutical & biotechnology companies and governments, coupled with the increasing focus on life science projects to develop new therapeutic & diagnostic products, is expected to aid the clinical trial imaging market.
Opportunity: Developing Countries;
Developing countries such as India, South Korea, Brazil, and Mexico offer significant growth opportunities to players operating in the clinical trial imaging market, mainly due to the growing R&D funding in these countries. These developing markets also have a strong trend of commercialization of life science research. With significant developments in life sciences research, these economies are expected to offer high growth opportunities in the market.
Furthermore, Asian markets, especially China and India, have many CROs that offer drug discovery services to pharmaceutical and biotechnology companies. With the significant increase in R&D funding and CROs operating in emerging countries, the demand for clinical trial imaging is expected to increase in these countries in the coming years.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=30446624&utm_source=openpr&utm_medium=referral
"In 2020, services segment accounted for the largest share of the clinical trial imaging market, by product and services"
The market is segmented into services and software based on product and services. The services segment accounted for the largest share of the market in 2020, mainly due to the increase in R&D spending and growth in pharmaceutical and biotechnology industries.
"In 2020, computed tomography segment accounted for the largest share of the clinical trial imaging market, by modality"
The market is segmented into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, echocardiography and other modalities based on modality. In 2020, the computed tomography segment accounted for the largest share. Factors such as increasing number of CROs, Increase in R&D spending and growth in pharmaceutical and biotechnology industries drive this market.
"In 2020, oncology segment accounted for the largest share of the clinical trial imaging market, by therapeutic area"
The market is segmented into oncology, infectious diseases, neurology, CVS, endocrinology, immunological disorder and other therapeutic area based on therapeutic area. In 2020, the oncology segment accounted for the largest share. Factors such as Increase in R&D spending and growth in pharmaceutical and biotechnology industries drive this market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=30446624&utm_source=openpr&utm_medium=referral
"North America is the largest regional market for clinical trial imaging market"
The global market is segmented into five major regions-North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global clinical trial imaging industry. The North American market's growth can be attributed to the, increase in R&D spending, increasing number of CROs, and growth in pharmaceutical and biotechnology industries.
Some key players in the clinical trial imaging market (2021- 2026):
ICON plc. (Ireland), BioTelemetry Inc. (US), Biomedical Systems Corporation (US), Medpace Holdings, Inc. (US), IXICO plc. (UK), Resonance Health Ltd. (Australia), Radiant Sage LLC. (US), BioClinica Inc. (US), Intrinsic Imaging LLC. (US), Cardiovascular Imaging Technologies LLC. (US), Medical Metrics Inc. (US), Prism Clinical Imaging, Inc. (US), Boston Imaging Core Lab LLC. (US), anagram 4 clinical trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC. (US), Micron Inc. (Japan), Imaging Endpoints LI, LLC (US), Perspectum Ltd. (UK), Pharmtrace klinische Entwicklung GmbH (Germany), WorldCare Clinical, LLC (US)
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=30446624&utm_source=openpr&utm_medium=referral
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clinical Trial Imaging Market by 2026 - Global Trends, Share Analysis, Leading Players, Business Opportunities here
News-ID: 2748579 • Views: …
More Releases from MarketsandMarkets™.
Bone Growth Stimulator Market worth $1.8 billion by 2027 - Leading Key Players a …
- Bone Growth Stimulator Market is projected to grow from USD 1.4 billion in 2022 to USD 1.8 billion by 2027, at a CAGR of 5.9% from 2022 to 2027, according to a new report by MarketsandMarkets™. The growth of the global bone growth stimulators market can be attributed to factors such as increasing research activities for the development of novel bone growth stimulators devices, growing demand for bone growth…
Protein Expression Market worth $5.4 billion by 2027 - Exclusive Report by Marke …
Protein Expression Market is projected to grow from USD 2.9 billion in 2022 to USD 5.4 billion by 2027, at a CAGR of 13.3% from 2022 to 2027, according to a study published by MarketsandMarkets™. The Factors such as the increasing incidence of chronic diseases, increasing research activities on recombinant-based protein expression, growth in the life sciences and biopharmaceutical industries, as well as the availability of funding for protein-based research.…
OTC Braces & Supports Market worth $1,286 million by 2027 - Exclusive Report by …
The OTC Braces and Supports Market is valued at an estimated USD 942 million in 2022 and is projected to reach USD 1,286 million by 2027, at a CAGR of 6.4%, according to a new report by MarketsandMarkets™. Market growth is driven by the rising technological advancements in OTC braces and supports, increasing orthopedic disorders and the growing awareness of preventive diagnosis in developing countries. Emerging economies such as China,…
Artificial Intelligence (AI) in Medical Diagnostics Market worth $5.5 billion by …
Artificial Intelligence (AI) in Medical Diagnostics Market is projected to grow from USD 1.0 billion in 2022 to USD 5.5 billion by 2027, at a CAGR of 39.9% from 2022 to 2027, according to a new report by MarketsandMarkets™. The application of AI in medical diagnostics is growing at a fast pace owing to factors such as growing government initiatives to drive the adoption of AI-based technologies, rise in adoption…
More Releases for Imaging
Mobile Gamma Cameras Market 2018 -- 2028 | By Indication Type (Cardiac Imaging, …
Mobile gamma camera is a portable version of the stationary gamma or angler camera used for nuclear imaging. Nuclear imaging involves injecting a radio nucleotide in the body or organ under study and record the resulting redioactivity by scanning with a gamma camera. Nuclear imaging is performed owing to its better resolution and selectivity than non-nuclear imaging such as MRI and ultrasound.
The mobile gamma camera types include single, dual and…
Holographic Imaging Market Latest Technological Innovations on Holoxica, Zebra I …
Market Study Report Adds Global Holographic Imaging Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Emergence of 3D holographic imaging has revolutionized the medical imaging and surgery. The technology converts the given two dimensional MRI and CT scan imaging data into interactive virtual reality images. Using these images doctors…
Holographic Imaging Market : Eminent Players – EON Reality, Holoxica, Zebra Im …
Holographic Imaging Market size is set to exceed USD 3 billion by 2024; according to a new research study published by Global Market Insights, Inc.
Increasing adoption of holographic imaging in medical education should drive the holographic imaging market size over the forecast years. Medical practitioners and students are widely using holographic techniques to effectively study the human body, since the technology provides surgeons with a detailed view of patient…
Holographic Imaging Market Eminent Players – EON Reality, Holoxica, Zebra Imag …
Holographic Imaging Market size is set to exceed USD 3 billion by 2024; according to a new research study published by Global Market Insights, Inc.
Increasing adoption of holographic imaging in medical education should drive the holographic imaging market size over the forecast years. Medical practitioners and students are widely using holographic techniques to effectively study the human body, since the technology provides surgeons with a detailed view of patient anatomy…
Holographic Imaging Market Projections Reviewed On Holoxica, Zebra Imaging, Oviz …
The newly released research at Market Study Report titled “2017-2024 Global Holographic Imaging Consumption Market Report” provides data, information, brief analysis, company profiles, statistics for past years and forecasts for next few years.
Holographic Imaging Market size is set to exceed USD 3 billion by 2024. U.S. holographic imaging market accounted for significant industry share with expectations to witness healthy growth over coming years. Increasing biomedical research initiatives in holographic image…
Digital Imaging Market,Digital Imaging Industry, Global Digital Imaging Market,D …
Latest industry research report on: Global Digital Imaging Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
This report presents the worldwide Digital Imaging market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application.
This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry…
